BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Nuvation Bio Reports Third Quarter 2021 Financial Results and Provides Business Update

  Nuvation Bio Inc. today reported financial results for the third quarter ended September 30, 2021, and provided a business update.

  November 10, 2021

   · 

  8 min read
• BioCapital

  Precigen to Present at the Stifel 2021 Virtual Healthcare Conference

  Precigen, Inc today announced that Helen Sabzevari , PhD, President and CEO of Precigen, will participate in the Stifel 2021 Virtual Healthcare Conference on Wednesday, November 17. 2021 at 10:40 AM ET.

  November 10, 2021

   · 

  2 min read
• Business

  Trevi Therapeutics Announces Third Quarter 2021 Financial Results and Business Update

  Trevi Therapeutics, Inc. today announced financial results for the quarter ended September 30, 2021, as well as provided business updates.

  November 10, 2021

   · 

  8 min read
• Business

  Marker Therapeutics Reports Third Quarter 2021 Operating and Financial Results

  Marker Therapeutics, Inc. today provided a corporate update and reported financial results for the third quarter ended September 30, 2021.

  November 10, 2021

   · 

  8 min read
• Business

  Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company Update

  Schrödinger, Inc. today announced financial results for the third quarter ended September 30, 2021, and provided an update on the company.

  November 10, 2021

   · 

  18 min read
• Business

  Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates

  Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced financial results for the third quarter 2021, and provided an update on its clinical programs.

  November 10, 2021

   · 

  9 min read
• Business

  Navidea Biopharmaceuticals Reports Third Quarter 2021 Financial Results

  Navidea Biopharmaceuticals, Inc. today announced its financial results for the third quarter and year-to-date for the period ended September 30, 2021.

  November 10, 2021

   · 

  12 min read
• Business

  PhaseBio Reports Third-Quarter 2021 Financial Results and Recent Business Highlights

  PhaseBio Pharmaceuticals, Inc. today provided an update on corporate activities and reported third-quarter 2021 financial results.

  November 10, 2021

   · 

  12 min read
• Business

  Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Update

  Spectrum Pharmaceuticals, Inc. today announced financial results for the three-month period ended September 30, 2021 and provided a corporate update.

  November 10, 2021

   · 

  16 min read
• Pharm Country

  KORU Medical Announces FDA Clearance for Delivery of Hizentra® Prefilled Syringes

  Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), today announced 510k clearance for use of the KORU Medical FreedomEdge® infusion pump to deliver Hizentra® [immune globulin subcutaneous (human) 20% liquid] 20 mL prefilled syringes.

  November 10, 2021

   · 

  3 min read